BRIP1 (BACH1) variants and familial breast cancer risk: a case-control study

被引：29
|
作者：
Frank, Bernd [1 ]
Hemminki, Kari
Meindl, Alfons
Wappenschmidt, Barbara
Sutter, Christian
Kiechle, Marion
Bugert, Peter
Schmutzler, Rita K.
Bartram, Claus R.
Burwinkel, Barbara
机构：
[1] DKFZ, Helmholtz Univ Grp Mol Epidemiol, German Canc Res Ctr, Heidelberg, Germany
[2] DKFZ, Div Mol Genet Epidemiol, German Canc Res Ctr, Heidelberg, Germany
[3] Karolinska Inst, Ctr Family Med, Huddinge, Sweden
[4] Tech Univ Munich, Dept Obstet & Gynaecol, Klinikum Rechts Isar, D-8000 Munich, Germany
[5] Univ Cologne, Div Mol Gynaecooncol, Dept Obstet & Gynaecol, Ctr Clin, Cologne, Germany
[6] Univ Hosp Cologne, CMMC, Cologne, Germany
[7] Univ Heidelberg, Inst Human Genet, Heidelberg, Germany
[8] Univ Heidelberg, Fac Clin Med, Inst Transfus Med & Immunol, Red Cross Blood Serv Baden Wurttemberg Hessia, Mannheim, Germany
来源：
BMC CANCER | 2007年 / 7卷
关键词：
FANCONI-ANEMIA; BRCA1; SUSCEPTIBILITY; MUTATIONS; GENES; BRIP1/BACH1; PROTEIN; REPAIR;
D O I：
10.1186/1471-2407-7-83
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Background: Inactivating and truncating mutations of the nuclear BRCA1-interacting protein 1 (BRIP1) have been shown to be the major cause of Fanconi anaemia and, due to subsequent alterations of BRCA1 function, predispose to breast cancer ( BC). Methods: We investigated the effect of BRIP1 - 64G > A and Pro919Ser on familial BC risk by means of TaqMan allelic discrimination, analysing BRCA1/BRCA2 mutation-negative index patients of 571 German BC families and 712 control individuals. Results: No significant differences in genotype frequencies between BC cases and controls for BRIP1 - 64G > A and Pro919Ser were observed. Conclusion: We found no effect of the putatively functional BRIP1 variants - 64G > A and Pro919Ser on the risk of familial BC.
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Germline mutations in BRIP1 and PALB2 in Jewish high cancer risk families
    Catucci, Irene
    Milgrom, Roni
    Kushnir, Anya
    Laitman, Yael
    Paluch-Shimon, Shani
    Volorio, Sara
    Ficarazzi, Filomena
    Bernard, Loris
    Radice, Paolo
    Friedman, Eitan
    Peterlongo, Paolo
    FAMILIAL CANCER, 2012, 11 (03) : 483 - 491
  • [22] Whole exome sequencing of breast cancer (TNBC) cases from India: association of MSH6 and BRIP1 variants with TNBC risk and oxidative DNA damage
    Kumar, M. Aravind
    Naushad, Shaik Mohammad
    Narasimgu, Narasimhulu
    Naik, S. Nagaraju
    Kadali, Srilatha
    Shanker, Uday
    Narasu, M. Lakshmi
    MOLECULAR BIOLOGY REPORTS, 2018, 45 (05) : 1413 - 1419
  • [23] Impact of XRCC1 genetic variants on its tissue expression and breast cancer risk: A case-control study
    Abdel Ghafar, Muhammad Tarek
    El-Rashidy, Mohamed Ali
    Gharib, Fatma
    Al-Ashmawy, Ghada Mohammad
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2021, 62 (07) : 399 - 408
  • [24] Dominant-negative pathogenic variant BRIP1 c.1045G>C is a high-risk allele for non-mucinous epithelial ovarian cancer: A case-control study
    Flaum, Nicola
    van Veen, Elke M.
    Smith, Olivia
    Amico, Stephanie
    Newman, William G.
    Crosbie, Emma J.
    Edmondson, Richard
    Smith, Miriam J.
    Evans, D. Gareth
    CLINICAL GENETICS, 2022, 101 (01) : 48 - 54
  • [25] Further evidence for the contribution of the BRCA1-interacting protein-terminal helicase 1 (BRIP1) gene in breast cancer susceptibility
    Ren, L. P.
    Xian, Y. S.
    Diao, D. M.
    Chen, Y.
    Guo, Q.
    Dang, C. X.
    GENETICS AND MOLECULAR RESEARCH, 2013, 12 (04) : 5793 - 5801
  • [26] Male breast cancer risk associated with pathogenic variants in genes other than BRCA1/2: an Italian case-control study
    Bucalo, Agostino
    Conti, Giulia
    Valentini, Virginia
    Capalbo, Carlo
    Bruselles, Alessandro
    Tartaglia, Marco
    Bonanni, Bernardo
    Calistri, Daniele
    Coppa, Anna
    Cortesi, Laura
    Giannini, Giuseppe
    Gismondi, Viviana
    Manoukian, Siranoush
    Manzella, Livia
    Montagna, Marco
    Peterlongo, Paolo
    Radice, Paolo
    Russo, Antonio
    Tibiletti, Maria Grazia
    Turchetti, Daniela
    Viel, Alessandra
    Zanna, Ines
    Palli, Domenico
    Silvestri, Valentina
    Ottini, Laura
    EUROPEAN JOURNAL OF CANCER, 2023, 188 : 183 - 191
  • [27] BRIP1 overexpression is correlated with clinical features and survival outcome of luminal breast cancer subtypes
    Gupta, Ishita
    Ouhtit, Allal
    Al-Ajmi, Adil
    Rizvi, Syed Gauhar A.
    Al-Riyami, Hamad
    Al-Riyami, Marwa
    Tamimi, Yahya
    ENDOCRINE CONNECTIONS, 2018, 7 (01): : 65 - 77
  • [28] Rad51 paralogs and the risk of unselected breast cancer: A case-control study
    Gresner, Peter
    Jablonska, Ewa
    Gromadzinska, Jolanta
    PLOS ONE, 2020, 15 (01):
  • [29] BRCA1 interactors, RAD50 and BRIP1, as prognostic markers for triple-negative breast cancer severity
    Katheeja, Muhseena N.
    Das, Shankar Prasad
    Das, Ranajit
    Laha, Suparna
    FRONTIERS IN GENETICS, 2023, 14
  • [30] Prognostic Value Estimation of BRIP1 in Breast Cancer by Exploiting Transcriptomics Data Through Bioinformatics Approaches
    Khan, Umama
    Khan, Md Salauddin
    BIOINFORMATICS AND BIOLOGY INSIGHTS, 2021, 15
12345